Bob Durkin Quoted in Natural Products Insider Article on FDA’s Decision on β-NMN in Supplements

AGG attorney and member of the firm’s Dietary Supplements team, Bob Durkin, was quoted in a Natural Products Insider article titled “Trade Groups react to FDA decision on β-NMN in supplements.”

FDA made a recent determination that an anti-aging ingredient, β-NMN (beta-nicotinamide mononucleotide), cannot be lawfully marketed in dietary supplements. The decision is also a change in the agency’s position.

The issue stems from a provision in U.S. law that bars ingredients from being marketed in supplements if they were first approved or investigated as drugs.

Bob spoke with Natural Products Insider on FDA’s interpretation and application of the drug preclusion and its impact on pharmaceutical and dietary supplement companies.

To read the full article, please click here.